Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa | MicrobiomeTrials← Back to trialsNCT06058520
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2023-12-27Est. Completion: 2026-12-30
Enrollment target: 16 participants Locations- University of Minnesota, Minneapolis, Minnesota, United States
Other microbiome trials you might be interested in
Hidradenitis
This is a parallel, Phase 2b, 3-arm, double-blind, randomized, multicenter, multinational, placebo-controlled, dose-rang…
Multiple LocationsEst. completion Jun 16, 2028
VitiligoAtopic DermatitisAlopecia AreataHidradenitis Suppurativa (HS)
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatol…
New York, United StatesEst. completion Aug 3, 2041
Hidradenitis Suppurativa (HS)
This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chro…
Worcester, United StatesEst. completion Sep 2028